Neuralgic amyotrophy
Conditions
Interventions
Experimental group:For patients diagnosed with NA, basic treatment is provided, including neurotrophic drugs, anti-inflammatory and analgesic medications, and routine rehabilitation therapy. UGNB trea
Sponsors
Beijing Tsinghua Changgung Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients were diagnosed using diagnostic criteria that combine typical clinical presentations with electrophysiological examinations: acute or subacute onset, characterized by proximal pain in one upper limb, followed by muscle weakness; primarily motor impairment with mild sensory loss; physical examination may reveal reduced muscle strength in the affected limb, diminished or absent tendon reflexes, and/or muscle atrophy. Neurophysiological tests indicate nerve injury from the brachial plexus.
Exclusion criteria
Exclusion criteria: Excluding shoulder and elbow joint lesions, multifocal motor neuropathy, chronic inflammatory demyelinating radiculoneuropathy, polyneuropathy (such as vasculitic neuropathy) and neuronal lesions, diabetic peripheral neuropathy, motor neuron disease, Phalen's disease, thoracic outlet syndrome, malignant tumor invasion of the brachial plexus, hereditary pressure-sensitive peripheral neuropathy, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MRC score;mRS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| ADL score;Nerve conduction velocity; | — |
Countries
China
Contacts
Public ContactFeng Xinhong
Beijing Tsinghua Changgung Hospital
Outcome results
None listed